Houston company forms strategic alliance to enhance tech-enabled school security

in-class safety

School security emergency notification systems just got an upgrade. Photo via Getty Images

Students are back to school, and parents are back to worrying about their children's safety. Two companies have teamed up to enhance on-campus safety technology.

Houston-based Raptor Technologies, a school safety software provider, and Baltimore-based Alertus Technologies, provider of emergency mass notification solutions, announced earlier this month they will team up with their respective technologies to integrate enhance safety and security offerings in K-12 schools and districts.

The partnership, according to a news release, takes Alertus’ notification solutions and combines it with Raptor’s emergency management and reunification tools. Alertus’ tech includes Alertus Desktop, IP Text-to-Speech Interface for PA systems, and a range of hardwired and pocket-sized activation devices. With the integration, K-12 schools utilizing Raptor Technologies can automatically send emergency notifications to all alerting modalities unified by the Alertus Mass Notification System on Raptor Connect.

“School districts across the country are recognizing the value of being able to quickly initiate an alert and notify staff and teachers in the event of a school emergency,” says Chris Noell, chief product officer of Raptor Technologies, in the release. “By integrating with Alertus, we’re expanding the ways users can rapidly access Raptor Alert to trigger an alert and increasing the ways a campus can be notified of an emergency.”

Several states, including Texas, Florida, New Jersey and New York, have emphasized funding or mandates to make mobile panic alerts available to schools.

“Every second counts in an emergency and our top priority is ensuring that schools have every possible way to get urgent, life-saving information to their students, teachers and staff – both during and after a critical event,” says Patrick Dennin, director of education at Alertus, in the release. “Our integration with Raptor enables schools to alert, respond, and recover more effectively by reducing response times, reinforcing stakeholder responsibilities and mitigating risk to their communities.”

Over 7,500 schools nationwide are on Raptor's alert platform. Founded in 2002 and with over 100 employees at the company, Raptor Technologies received private equity funding and made a strategic international acquisition last year, InnovationMap reported.

From Your Site Articles
Raptor Technologies, a Houston-based company providing safety-focused software to schools, has made an acquisition and announced new investment. Graphic via raptortech.com

Houston-based edtech company makes international acquisition following strategic investments

M&A Moves

A Houston company that provides school safety software to schools across the country has made a strategic acquisition.

Raptor Technologies announced last week that it has acquired United Kingdom-based CPOMS, which provides student safeguarding software to schools in the UK. Raptor reported that the M&A activity follows strategic investments from Chicago-based Thoma Bravo and existing investors JMI Equity, a Maryland-based firm, and New York-based Ares Capital. The terms of the deal were not disclosed.

"We are excited to add CPOMS best-in-class wellbeing products to Raptor's market-leading school safety product suite and to welcome the CPOMS team into the Raptor family," says Gray Hall, CEO of Raptor Technologies, in the press release. "Combining CPOMS software and domain expertise with Raptor further advances our mission to protect every child, every school, every day. We are eager to bring the proven capabilities of CPOMS to the US market and continue advancing CPOMS leadership position in the UK."

Raptor was founded to provide schools with a suite of software that can help implement safety across visitor, volunteer, and emergency management services. The software that the CPOMS platform provides targets reporting abuse, cyberbullying, and more.

"Raptor was the perfect fit for CPOMS. Both companies have dedicated themselves to keeping schools and students safe and share very similar cultures," says John Wild, managing director at CPOMS, in the release. "We at CPOMS are excited about joining the Raptor organization and look forward to the enhanced growth opportunities ahead."

Hall will lead the expanded organization, and Wild will transition to managing director of UK Operations for Raptor and CPOMS.

The acquisition was connected to Raptor's recent funding. The company did not disclose the amount raised.

"School safety needs in the US and UK continue to evolve, with solutions for managing the wellbeing and safety of students being paramount," says Adam Solomon, a principal at Thoma Bravo, in the release. "Through this investment and acquisition, we see tremendous potential for Raptor to extend its market leadership in K-12 school safety and its continued deployment of innovative solutions to schools in the US and UK."

The Houston company was founded in 2003. In 2018, Raptor received investment from JMI Equity.

"Combining CPOMS with Raptor creates a company with unique capabilities to help schools manage the safety and wellbeing of their students," says Bob Nye, general partner at JMI Equity, in the release. "We're excited about this acquisition and the strategic opportunity ahead."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.


Houston researchers make headway on affordable, sustainable sodium-ion battery

Energy Solutions

A new study by researchers from Rice University’s Department of Materials Science and NanoEngineering, Baylor University and the Indian Institute of Science Education and Research Thiruvananthapuram has introduced a solution that could help develop more affordable and sustainable sodium-ion batteries.

The findings were recently published in the journal Advanced Functional Materials.

The team worked with tiny cone- and disc-shaped carbon materials from oil and gas industry byproducts with a pure graphitic structure. The forms allow for more efficient energy storage with larger sodium and potassium ions, which is a challenge for anodes in battery research. Sodium and potassium are more widely available and cheaper than lithium.

“For years, we’ve known that sodium and potassium are attractive alternatives to lithium,” Pulickel Ajayan, the Benjamin M. and Mary Greenwood Anderson Professor of Engineering at Rice, said in a news release. “But the challenge has always been finding carbon-based anode materials that can store these larger ions efficiently.”

Lithium-ion batteries traditionally rely on graphite as an anode material. However, traditional graphite structures cannot efficiently store sodium or potassium energy, since the atoms are too big and interactions become too complex to slide in and out of graphite’s layers. The cone and disc structures “offer curvature and spacing that welcome sodium and potassium ions without the need for chemical doping (the process of intentionally adding small amounts of specific atoms or molecules to change its properties) or other artificial modifications,” according to the study.

“This is one of the first clear demonstrations of sodium-ion intercalation in pure graphitic materials with such stability,” Atin Pramanik, first author of the study and a postdoctoral associate in Ajayan’s lab, said in the release. “It challenges the belief that pure graphite can’t work with sodium.”

In lab tests, the carbon cones and discs stored about 230 milliamp-hours of charge per gram (mAh/g) by using sodium ions. They still held 151 mAh/g even after 2,000 fast charging cycles. They also worked with potassium-ion batteries.

“We believe this discovery opens up a new design space for battery anodes,” Ajayan added in the release. “Instead of changing the chemistry, we’re changing the shape, and that’s proving to be just as interesting.”

---

This story originally appeared on EnergyCapitalHTX.com.

View All Listings